NEWSROOM

Latest Learnings

Get the latest insights, news, and expert articles from Viromme.

LAtest News

Jan 26, 2025

Pre-Print

Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry

Jan 26, 2025

Pre-Print

Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry

Jan 26, 2025

Pre-Print

Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry

Jan 21, 2025

Announcement

Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral

Jan 21, 2025

Announcement

Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral

Jan 21, 2025

Announcement

Model Medicines, Icahn School of Medicine at Mount Sinai, and University of California, San Diego Researchers Publish Groundbreaking Preprint on MDL-001, A Broad-Spectrum Antiviral

Jan 14, 2025

Pre-Print

MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases

Jan 14, 2025

Pre-Print

MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases

Jan 14, 2025

Pre-Print

MDL-001: An Oral, Safe, and Well-Tolerated Broad-Spectrum Inhibitor of Viral Polymerases

Apr 8, 2024

Pre-Print

RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor

Apr 8, 2024

Pre-Print

RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor

Apr 8, 2024

Pre-Print

RdRp Thumb-1, A Universal RNA Antiviral Target, and MDL-001, a Potent Inhibitor